Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 19 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 11565001

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  2. US 11566253

    Targeted gene demethylation in plants

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  3. US 11559585

    Conjugates of active pharmaceutical ingredients

    The Regents of the University of California · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

  4. US 11560356

    Compounds and compositions for the treatment of cancer

    The Regents of the University of California · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

  5. US 11560561

    Modular polypeptide libraries and methods of making and using same

    The Regents of the University of California · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

  6. US 11554180

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  7. US 11555057

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  8. US 11555055

    Peptide inhibitors of insulin-degrading enzyme

    The Regents of the University of California · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  9. US 11549127

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  10. US 11547664

    Compositions and methods for treating eosinophilic disorders

    The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  11. US 11547663

    Unit aerosol doses for anticoagulation

    The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  12. US 11548953

    Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof

    The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  13. US 11547674

    Protein-polymer hybrid biomaterials

    The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  14. US 11541125

    Noncrushable pill formulations

    The Regents of the University of California · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  15. US 11541044

    K-Ras modulators

    The Regents of the University of California · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  16. US 11536727

    Therapeutic antibodies against ROR-1 protein and methods for use of same

    The Regents of the University of California · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  17. US 11530421

    Self-inactivating endonuclease-encoding nucleic acids and methods of using the same

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  18. US 11530259

    Therapies and methods to treat TLR2-mediated diseases and disorders

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  19. US 11530398

    CRISPR-Cas effector polypeptides and methods of use thereof

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  20. US 11530240

    Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  21. US 11524948

    Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate, and uses thereof

    The Regents of the University of California · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted

  22. US 11524053

    Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents

    The Regents of the University of California · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted

  23. US 11518818

    Therapeutic anti-IgE antibodies and methods and compositions thereof

    The Regents of the University of California · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted

  24. US 11510929

    Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids

    The Regents of the University of California · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.